Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

Fig. 3

Composition of the bacterial gut microbiota. A Proportion of different phyla in each sample. B-L Relative abundance of top 11 phylum across groups. B-D One-way ANOVA and Tukey’s multiple comparisons test were used, and data were shown as mean ± SD; E-L Kruskal-Wallis and Dunn’s multiple comparisons test were used, and data were shown as median and IQR. *P < 0.05; **P < 0.01; ***P < 0.001

Back to article page